Form 4: Bausch Health Director John Paulson Increases Direct Stake Through Restricted Share Units

Bausch Health Companies Inc. Director John Paulson acquired 9,384 common shares through Restricted Share Units as compensation for his board service, increasing his direct beneficial ownership.

Summary

• John Paulson, a Director and 10% Owner of Bausch Health Companies Inc. (BHC), acquired 9,384 common shares.
• The acquisition occurred on June 30, 2025, and represents Restricted Share Units (RSUs) issued in lieu of cash compensation for his service on the Issuer's Board of Directors for the quarter ending June 30, 2025.
• Each RSU represents a contingent right to receive one common share, with a transaction price of $0, indicating it was compensation.
• Following this transaction, John Paulson directly beneficially owns 341,439 common shares.
• Additionally, John Paulson indirectly beneficially owns 32,791,702 common shares through managed funds, where Paulson Capital Inc. is the investment manager and John Paulson is the controlling person.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director through equity compensation is generally positive as it aligns the director's interests with shareholders, indicating commitment. However, it's not a direct cash investment.

Positives

• The issuance of Restricted Share Units to a director aligns management's interests with those of shareholders, as the director's compensation is tied to the company's share performance.
• The director's increased direct beneficial ownership demonstrates continued commitment to the company.

Negatives

• The acquisition was through compensation (RSUs) rather than a direct cash purchase, meaning no new capital was invested by the director.

Future Outlook

The document, an SEC Form 4, reports a past insider transaction and does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• John Paulson, the controlling person of Paulson Capital Inc., serves on the board of directors of the Issuer.
• Paulson Capital Inc. is the investment manager of investment funds (the 'Funds') that directly own a significant portion of the reported securities.
• The reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein.
• This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically the issuance of equity compensation to a director. Such transactions are common practice across industries to align the interests of corporate leadership with those of shareholders. It does not provide specific insights into broader industry trends but reflects standard corporate governance practices.

Comparison to Industry Standards

• The practice of compensating directors with Restricted Share Units (RSUs) is a common corporate governance standard across publicly traded companies, including those in the pharmaceutical and healthcare sectors like Bausch Health Companies Inc.
• This method of compensation is widely used to align the financial interests of board members with the long-term performance of the company's stock, similar to practices at peer companies such as Pfizer, Johnson & Johnson, or AbbVie, where equity-based compensation forms a significant part of executive and director remuneration.

Corporate Governance

Related Party Transactions

• The issuance of 9,384 Restricted Share Units to John Paulson, a director, constitutes a transaction between the company and a related party (a member of its board of directors).
• John Paulson's indirect beneficial ownership of 32,791,702 shares through Paulson Capital Inc. and its managed funds represents a related party structure, as he is the controlling person of the investment manager.

Stakeholder Impact

• Shareholders: The issuance of equity compensation to a director aligns their interests with shareholders, potentially leading to decisions that enhance shareholder value.
• Management: The director's compensation structure is tied to the company's equity performance.

Key Dates

Keywords

Bausch Health, BHC, John Paulson, Form 4, Insider Transaction, Director Compensation, Restricted Share Units, RSU, Beneficial Ownership, Corporate Governance